ATE119390T1 - Arzneimittel. - Google Patents

Arzneimittel.

Info

Publication number
ATE119390T1
ATE119390T1 AT91907023T AT91907023T ATE119390T1 AT E119390 T1 ATE119390 T1 AT E119390T1 AT 91907023 T AT91907023 T AT 91907023T AT 91907023 T AT91907023 T AT 91907023T AT E119390 T1 ATE119390 T1 AT E119390T1
Authority
AT
Austria
Prior art keywords
sodium
carbonate
plus
malic
granules
Prior art date
Application number
AT91907023T
Other languages
English (en)
Inventor
David Roy Merrifield
Paul Laurence Carter
David George Smithklin Doughty
Road Bottom
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10674100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE119390(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of ATE119390T1 publication Critical patent/ATE119390T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
AT91907023T 1990-04-07 1991-04-02 Arzneimittel. ATE119390T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007945A GB9007945D0 (en) 1990-04-07 1990-04-07 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ATE119390T1 true ATE119390T1 (de) 1995-03-15

Family

ID=10674100

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91907023T ATE119390T1 (de) 1990-04-07 1991-04-02 Arzneimittel.

Country Status (12)

Country Link
EP (1) EP0524211B2 (de)
JP (1) JP3234946B2 (de)
AT (1) ATE119390T1 (de)
AU (1) AU7558691A (de)
CA (1) CA2079904A1 (de)
DE (1) DE69108022T3 (de)
GB (1) GB9007945D0 (de)
IE (1) IE911148A1 (de)
NZ (1) NZ237710A (de)
PT (1) PT97264A (de)
WO (1) WO1991015197A1 (de)
ZA (1) ZA912538B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
FR2714064B1 (fr) * 1993-12-16 1996-03-08 Edmond Creppy Aspartame pour son application en tant que substance thérapeutiquement active.
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
DK0862431T3 (da) * 1995-09-07 2002-03-11 Smithkline Beecham Plc Anvendelse af pædiatrisk farmaceutisk formulering omfattende amoxycillin og clavulanat
GB9616728D0 (en) * 1996-08-09 1996-09-25 Conte Rolland R Process, product and package
GB9617658D0 (en) * 1996-08-23 1996-10-02 Conte Rolland R Process
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
IL145580A0 (en) * 1999-04-13 2002-11-10 Beecham Pharm Pte Ltd A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
SI20411A (sl) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Vodotopni praški za peroralno raztopino in njihova uporaba
FR2812199A1 (fr) * 2000-07-31 2002-02-01 Maximun Frederic Yanze Nouvelles compositions pharmaceutiques effervescentes contenant la chloroquine
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1541129A1 (de) * 2003-12-12 2005-06-15 Cimex AG Amoxycillin und Clavulanat enthaltende pharmazeutische Brauseformulierung
WO2014174405A1 (en) * 2013-04-22 2014-10-30 Webb Johannes Arnoldus Vosloo Pharmaceutical preparation
CN116115571A (zh) * 2023-04-04 2023-05-16 内蒙古联邦动保药品有限公司 高浓度阿莫西林可溶性粉剂及其制备方法
CN118267361B (zh) * 2024-05-31 2024-08-23 潍坊格润药业有限公司 一种兽用复方阿莫西林可溶性粉

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT307616B (de) * 1969-05-02 1973-05-25 Biochemie Gmbh Verfahren zur Herstellung einer Brausezubereitung
EP0080862B1 (de) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmazeutische Zubereitung die Beta-Lactam Antibiotika enthält
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
LU85943A1 (fr) * 1985-06-12 1987-01-13 Galephar Comprimes pharmaceutiques permettant l'administration aisee de pellets, leur preparation et leur utilisation
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.

Also Published As

Publication number Publication date
EP0524211B1 (de) 1995-03-08
CA2079904A1 (en) 1991-10-08
EP0524211A1 (de) 1993-01-27
NZ237710A (en) 1993-05-26
PT97264A (pt) 1992-01-31
AU7558691A (en) 1991-10-30
EP0524211B2 (de) 1999-08-11
DE69108022D1 (de) 1995-04-13
JP3234946B2 (ja) 2001-12-04
ZA912538B (en) 1992-04-29
DE69108022T2 (de) 1995-07-20
IE911148A1 (en) 1991-10-09
JPH05505193A (ja) 1993-08-05
WO1991015197A1 (en) 1991-10-17
DE69108022T3 (de) 2000-04-20
GB9007945D0 (en) 1990-06-06

Similar Documents

Publication Publication Date Title
DE69108022D1 (de) Arzneimittel.
ATE232092T1 (de) Ein brause-säure-basepaar enthaltende arzneimittel
HU9503085D0 (en) Veterinary composition containing a proton pump inhibitor
DE58900594D1 (de) Ibuprofen-brausezubereitungen.
NO910213L (no) Fremgangsmaate for fremstilling av orale legemiddelformer av pimobendan.
SE8902288D0 (sv) Farmaceutisk komposition
DE69309540D1 (de) Orale Arzneimittel mit kolonspezifischer Freisetzung
ATE205090T1 (de) Eine glucagon enthaltende pharmazeutische zubereitung
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
SE9402431D0 (sv) New tablet formulation
ITBO910024A1 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
ATE83651T1 (de) Acetylcystein enthaltende mundloesliche arzneimittel.
ITMI941262A0 (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
NO302368B1 (no) Kinoksalinforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse av forbindelsene for fremstilling av preparatene
LV10268A (lv) Terapeitiski aktivs benzimidazols un ta iegusanas panemiens
CA2283408A1 (en) Swallow tablet comprising paracetamol
DE69202696D1 (de) Arzneimittel enthaltend Ranitidin/Wismutcarboxylat-Salze.
IS4212A (is) Aðferð til framleiðslu á N-metýl-3-(1-metýl-4-píperidinýl)-1H-indól-5- etansúlfonamíð og lífeðlisfræðilega viðunandi söltum þess og lausnum þeirra
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
DE3889504D1 (de) Aromatisierte filmbeschichtete Tablette.
GB1327560A (en) Effervescent pharmaceutical preparations
MY106672A (en) Dichloroaniline compound.
NO923808L (no) Substituert sulfonamidderivat og farmasoeytisk formuleringinneholdende det samme
IL103743A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IL96814A0 (en) 3-l-(5-thioxo-l-prolyl)thiazolidine-4-carboxylic acid and derivatives therefrom,processes for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties